en
Scientific article
French

Les antileucotriènes dans le traitement de l'asthme

Published inRevue médicale suisse, vol. 2, no. 77, p. 1997-1998,2000-1
Publication date2006
Abstract

This review aims to evaluate the efficacy of the leukotriene modifiers in the different stages and subgroups of asthma. In mild asthma, they bring some improvement as monotherapy, but less than inhaled steroids. In moderate asthma, leukotriene modifiers associated with inhaled steroids seem to offer a slight advantage over placebo. No evidence of additional effect has been published in severe asthma. Exercice- and aspirin-induced asthma are particulary responsive to leukotriene modifiers. This treatment may also play a role in acute asthma. In practice, it is possible to select patients who benefit from those molecules. If only these "responders" are treated, leukotriene modifiers are an adequate treatment, easy to use and well tolerated.

engfre
Keywords
  • Asthma
  • Humans
  • Leukotriene Antagonists
Citation (ISO format)
GEX, Grégoire, NENDAZ, Mathieu, JANSSENS, Jean-Paul. Les antileucotriènes dans le traitement de l’asthme. In: Revue médicale suisse, 2006, vol. 2, n° 77, p. 1997–1998,2000–1.
Identifiers
ISSN of the journal1660-9379
417views
0downloads

Technical informations

Creation12.07.2010 14:37:43
First validation12.07.2010 14:37:43
Update time14.03.2023 15:55:03
Status update14.03.2023 15:55:03
Last indexation15.01.2024 20:55:41
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack